Tkg Advisors, LLC Biogen Inc. Transaction History

Tkg Advisors, LLC

  • $197 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 20, 2023
SELL
$275.25 - $318.06 $49,269 - $56,932
-179 Reduced 1.64%
10,717 $3.05 Million
Q1 2023

Apr 19, 2023
BUY
$256.56 - $292.34 $217,819 - $248,196
849 Added 8.45%
10,896 $3.03 Million
Q4 2022

Jan 27, 2023
BUY
$252.44 - $306.72 $2.54 Million - $3.08 Million
10,047 New
10,047 $2.78 Million

Others Institutions Holding BIIB

# of Institutions
1,018
Shares Held
128M
Call Options Held
1.22M
Put Options Held
1.4M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Tkg Advisors, LLC Portfolio

Follow Tkg Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tkg Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tkg Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email